Clinical trials
Phase 1 Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 3 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 3 |
| Guangdong Hengrui Pharmaceutical Co., Ltd | 2 |
| Guangzhou JOYO Pharma Co., Ltd | 2 |
| Bristol-Myers Squibb | 1 |
| Cedars-Sinai Medical Center | 1 |
| Celgene | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Endeavor Biomedicines, Inc. | 1 |
| Gilead Sciences | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 30 |
| Idiopathic Pulmonary Fibrosis | 11 |
| Lung Diseases | 5 |
| Lung Diseases, Interstitial | 4 |
| Cystic Fibrosis | 3 |
| Fibrosis | 3 |
| Idiopathic Interstitial Pneumonias | 3 |
| Bronchiectasis | 2 |
| Emphysema | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.